Imunogenicidade e resistência à toxina botulínica em procedimentos estéticos
Revista ft · 31.05.2026 · 30 (158) · 01-21
DOI: 10.69849/v3mvaw39 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 31.05.2026. Verfasst von Deborah Bacatole da Silva und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Botulinum toxin type A has become one of the most important tools in modern aesthetics, being widely used in minimally invasive treatments, mainly to soften dynamic wrinkles and expression lines. Its popularity is explained by its efficiency, safety, and speed of results. Even so, with continuous use, some patients may experience a reduction or even a lack of response to treatment. This situation is frequently related to the immunogenicity of the substance, which consists of the product's ability to induce the immune system to form neutralizing antibodies, which prevent the drug from acting correctly. The objective of this research was to investigate the link between immunogenicity and the development of resistance to botulinum toxin in the aesthetic field, identifying the elements that most contribute to this phenomenon. The work consisted of an integrative literature review, with data collected from important scientific databases, both national and international. The results showed that the use of high doses, applications with very short intervals, an excessive number of sessions, and certain characteristics of commercial formulations are factors that increase the chance of treatment failure over time. Although the incidence of immunological resistance is considered low in clinical practice, its occurrence still represents a challenge for professionals. Therefore, it is concluded that the use of personalized protocols, respect for the correct intervals between sessions, and the careful application of the substance are fundamental to reducing risks and ensuring the prolonged effectiveness of aesthetic procedures.
Zitieren
APA
Silva, D. B. D., Santos, M. L. O. D., Leão, J. B., Bastos, S. R., Carmo, A. S. D., & Andrade, L. S. M. (2026). Imunogenicidade e resistência à toxina botulínica em procedimentos estéticos. Revista ft, 30(158), 01-21. https://doi.org/10.69849/v3mvaw39
Vancouver
Silva DBD, Santos MLOD, Leão JB, Bastos SR, Carmo ASD, Andrade LSM. Imunogenicidade e resistência à toxina botulínica em procedimentos estéticos. Revista ft. 2026;30(158):01-21. doi:10.69849/v3mvaw39
BibTeX
@article{Silva2026,
author = {Silva, Deborah Bacatole da and Santos, Maria Luiza Oliveira dos and Leão, Jacson Batista and Bastos, Suhelen Ramos and Carmo, Adricia Santos do and Andrade, Lorena Silva Matos},
title = {Imunogenicidade e resistência à toxina botulínica em procedimentos estéticos},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {158},
pages = {01--21},
doi = {10.69849/v3mvaw39}
}
EUVIMED